Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

HIV Drugs in Development

Show Archived (Historical) Articles

New Drug Overview

Other Antiretroviral Drugs in Development (April 18, 2009)
To read PDF, click here
From AIDS InfoNet
Protease Inhibitors in Development (April 18, 2009)
To read PDF, click here
From AIDS InfoNet
Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV (April 17, 2009)
Study will assess safety and efficacy of single-tablet regimen containing elvitegravir boosted by GS 9350 and Truvada compared to Atripla.
From Gilead Sciences, Inc.
HIV Drugs in the Pipeline (March/April 2009)
A concise summary of drugs further along in development.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Combining New Drugs (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
New Pharmaco-Enhancers (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Non-Nucleoside Reverse Transcriptase Inhibitors in Development (February 6, 2009)
To read PDF, click here
From AIDS InfoNet
Immune Therapies in Development (November 3, 2008)
To read PDF, click here
From AIDS InfoNet
The Coming Crisis (October 2008)
To read PDF, click here
In GMHC Treatment Issues, from Gay Men's Health Crisis
Nucleoside Analog Reverse Transcriptase Inhibitors in Development (June 18, 2008)
To read PDF, click here
From AIDS InfoNet
The Coming Crisis in HIV Drug Development (June 16, 2008)
From Project Inform
Novel HIV Therapy Suffers Stunning Setback (June 12, 2008)
From Project Inform
Compound Has Potential for New Class of AIDS Drugs (May 14, 2008)
From University of Michigan
Update From CROI 2008 on Experimental Drugs (April 2008)
To read PDF, click here
In Project Inform Perspective, from Project Inform
Update on New Antiretroviral Drugs (November/December 2007)
An interview with Harold Kessler, M.D.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Update on Experimental Antiretrovirals (October 2007)
To read PDF, click here
In Project Inform Perspective, from Project Inform
Proof of Concept Study May Point to a Cure (July 2, 2007)
From Project Inform
2007 Antiretrovirals in Development Pipeline (March 23, 2007)
From Treatment Action Group
New Drugs From Old Classes (Spring 2006)
A listing of NNRTIs, NRTIs and protease inhibitors currently in development.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
Potential New Drug Options for People With Multidrug Resistance (Spring 2006)
If you have multidrug resistance, joining a clinical trial for a drug in development may carry risks as well as benefits.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
HIV Antiretroviral Agents in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body PRO
Oral Abstracts and Research Overview: Antiretroviral Therapy I: New Agents and New Insights (MP3) (February 6, 2006)
Podcast of presentations from CROI 2006; also available as an audio Webcast and a video Webcast.
From 13th Conference on Retroviruses and Opportunistic Infections
HAART Turns 10 (January/February 2006)
At the 10-year anniversary of the combination HIV treatment era, Guy Pujol takes a look back at how far we've come, and on what the next 10 years may hold in store.
To read PDF, click here
In Survival News, from AIDS Survival Project

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.